23.03.2013 Views

Name of Manual - Blue Cross and Blue Shield of Minnesota

Name of Manual - Blue Cross and Blue Shield of Minnesota

Name of Manual - Blue Cross and Blue Shield of Minnesota

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Coding Policies <strong>and</strong> Guidelines (Behavioral Health)<br />

Opioid Maintenance<br />

Drug Therapy<br />

(continued)<br />

11-42<br />

Buprenorphine administration is a pr<strong>of</strong>essional service that<br />

should be billed on an 837P claim format. This charge will<br />

deny if incorrectly submitted on an 837I. When administered<br />

as part <strong>of</strong> a program, procedure code H0047 (along with a<br />

narrative stating this is for buprenorphine) should be billed<br />

with diagnosis code 304.01. When administered in the <strong>of</strong>fice,<br />

the appropriate <strong>of</strong>fice visit or evaluation management<br />

procedure code should be billed with diagnosis code 304.01.<br />

Buprenorphine administration applies to the member’s<br />

substance abuse benefits for <strong>of</strong>fice visits, <strong>and</strong> these charges<br />

will not be applied to any accumulation maximums for the<br />

member. The injectable form <strong>of</strong> buprenorphine hydrochloride<br />

should be billed as code J0592 with one unit per 0.1 mg<br />

dosage.<br />

Tobacco Cessation Submit diagnosis code 305.1 or V15.82 if the intent is<br />

counseling <strong>and</strong>/or visit to obtain a prescription for smoking<br />

cessation medication/patches.<br />

If linked to an E/M service, a preventative or general illness<br />

benefit will be applied depending on the member’s benefits.<br />

Do not use 305.1 or V15.82 as the primary diagnosis if the<br />

member has a primary behavioral health diagnosis (such as<br />

depression) that is being treated but the member also uses<br />

tobacco. If this is the case, 305.1 or V15.82 should be listed as<br />

a secondary diagnosis.<br />

Hypnotherapy (code 90880), bi<strong>of</strong>eedback (codes 90875-<br />

90876), <strong>and</strong> acupuncture (codes 97810- 97811, 97813-97814)<br />

are considered investigative for treatment <strong>of</strong> tobacco use,<br />

dependence, <strong>and</strong> withdrawal, <strong>and</strong> are ineligible for<br />

reimbursement.<br />

Nicotine replacement therapies <strong>and</strong> bupropion for the treatment<br />

<strong>of</strong> tobacco dependence are subject to the member’s pharmacy<br />

benefits.<br />

Coverage for the treatment <strong>of</strong> tobacco dependence is subject to<br />

the member’s contract benefits.<br />

Any inpatient treatment service for tobacco cessation should be<br />

prior authorized, as they will be reviewed for medical<br />

necessity.<br />

<strong>Blue</strong> <strong>Cross</strong> <strong>and</strong> <strong>Blue</strong> <strong>Shield</strong> <strong>of</strong> <strong>Minnesota</strong> Provider Policy <strong>and</strong> Procedure <strong>Manual</strong> 06/19/12

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!